March 17 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T :
* HEALTH CANADA APPROVES NEW INDICATION FOR LUNG CANCER TREATMENT OPTION ALUNBRIG®
* TAKEDA CANADA INC. - HEALTH CANADA HAS ISSUED ALUNBRIG(BRIGATINIB TABLETS) MARKETING AUTHORIZATION WITHOUT CONDITIONS